Amaxa LV Unit for engineered therapeutic cells for regenerative medicine

Grant Project Details:

Awardee:
Neil Otto, PhD
Timeframe:
2019-2020
Location:
B-MoGen Biotechnologies | Minneapolis, MN
Amount:
$100,000
Status:
In Process
View all grants awarded

Grant timeline: proposal, updates, reports

Grant Location

B-MoGen Biotechnologies
614 McKinley Pl NE
Minneapolis, MN 55413

Grant Description

The ultimate goal is to provide our gene transfer transposon/transposase platforms to the rapidly growing field of gene modified cell therapy. B‐MoGen will utilize it’s non‐viral gene transfer technology, Tc Buster, to engineer MSCs and iPSCs as a vehicle to efficiently deliver therapeutic proteins to local sites of inflammation for the regeneration of healthy tissues.

Grant Awardee Biography

image of Neil Otto, PhD